SFAC. 10-Q/A. PR's: New Investment. Share Buy back
Post# of 63696
SFAC. 10-Q/A . PR's: New Investment. Share Buy back. Video.
(5 hours ago) SafeCode Drug Technologies Receives Investment From Biomedix Ltd
Biomedix is an Israel-based, publicly-traded Life Science (BMDX) has agreed to fund and purchase SAFC shares at 0.15 cents per share . Biomedix currently holds $200,000 USD worth of SafeCode Drug Technologies shares on its books.
1/2/13 SafeCode Drug Technologies Corporation Announce Share Buy Back Program
SafeCode Drug Technologies Corp is authorized to repurchase up to 1 million of its outstanding shares of common stock at a price up to $0.20 per share on the open market